The Latest Cardiac and Vascular News
HELP study exceeds target enrollment with 37 patients 84% initial open-label lead-in response rate to qualify for randomization Pulmonary capillary wedge pressure (PCWP) was reduced, on average, by 7.5 mmHg during exercise following the initial levosimendan infusion No serious drug-related adverse events have been reported to date Top-line data expected […]
Paragonix SherpaPak™ Cardiac Transport System is the only FDA cleared and CE marked device that safeguards hearts between donor and recipient patients CAMBRIDGE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc. today announced AdventHealth (Orlando, Florida) has adopted its Paragonix SherpaPak™ Cardiac Transport System (CTS) for the preservation of donor hearts for transplantation. A recent […]
The MIT-spinoff commercializing a clinical grade, heart monitoring “Smart Bra” for cardiovascular disease represents the first Femtech investment outside of the reproductive health and breast cancer space CAMBRIDGE, Mass.–(BUSINESS WIRE)–Health technology company Bloomer Tech (Bloomer) today announced that it has raised $3M in a Series Seed funding round. Material Impact, who […]
NEW YORK, March 12, 2020 (GLOBE NEWSWIRE) — Heartbeat Health, a leading digital health company aimed at improving heart health and addressing cardiovascular disease, announced today that it has closed $8.2 million in Series A funding led by .406 Ventures and Optum Ventures, with participation from existing investors Kindred Ventures, Lerer Hippeau, Designer Fund and Max Ventures. “Evolving trends […]
STOCKHOLM, March 12, 2020 /PRNewswire/ — Mentice AB (STO: MNTC), a world leader in simulation solutions for endovascular therapies, introduces Coronary Intermediate as the latest software addition to the Coronary Product Portfolio. Coronary Intermediate follows the introduction of Coronary Essentials three months earlier at the 20th International Meeting on Simulation in Healthcare […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix® Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has received approval from the United States Food and Drug Administration (FDA) for the Alto™ Abdominal Stent Graft System (Alto). The Company received approval based on its […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, announces the appointment of Will McGuire as Chief Executive Officer and a member of the company’s Board of Directors, effective March 30, 2020. Andrew Jackson, who […]
PORTLAND, Ore., March 9, 2020 /PRNewswire/ — VisCardia Inc., a privately held medical device developer, announced today it has completed the company’s First-in-Human study of the implantable VisONE® system for medically refractory heart failure (HF) patients with reduced ejection fraction (HFrEF) and preserved ventricular synchrony. The VisONE Heart Failure pilot was a prospective, […]
TUCSON, AZ, March 09, 2020 (GLOBE NEWSWIRE) — With the FDA approval of the SynCardia Systems, LLC 50cc TAH-t system a greater number of cardiac transplant eligible patients at risk of imminent death from biventricular failure now have access to total artificial heart therapy. The 50cc TAH-t is 37.5% smaller […]
– Sotalol IV is now approved for 1-day hospital outpatient initiation of AFib therapy and faster dose escalations for existing patients – New FDA-approved dosing, monitoring and evaluation shortens the hospital stay from 3 days to 1 day – The new initiation provides physicians with a faster and safe way […]
